Flowpoint Bio, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCincinnati, OH
SAM.gov UEICTZ3HKTXFEW9
FlowPoint Bio develops NEST, a cell engineering platform that delivers large genetic payloads directly into cell nuclei without viral vectors or electroporation. The technology is designed for academic research labs and biotech developers working with cell types including HSCs, iPSCs, NK cells, and CAR-T cells, and can deliver constructs exceeding 10kB with over 90% cell viability. The company serves the cell therapy and stem cell engineering industries.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Flowpoint Bio, INC. | Cincinnati | OH | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.